| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/ONC.2012.209 |
| P8608 | Fatcat ID | release_ty2wauw2sfgfjbdurxy6ji6534 |
| P932 | PMC publication ID | 3630485 |
| P698 | PubMed publication ID | 22751131 |
| P5875 | ResearchGate publication ID | 228103050 |
| P2093 | author name string | N G Ahn | |
| E M Anderson | |||
| K Sullivan | |||
| M M Gross | |||
| K L Couts | |||
| P2860 | cites work | Human MicroRNA targets | Q21563637 |
| Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling | Q24321740 | ||
| The role of microRNA genes in papillary thyroid carcinoma | Q24535848 | ||
| MicroRNA targeting specificity in mammals: determinants beyond seed pairing | Q24607724 | ||
| miRiad roles for the miR-17-92 cluster in development and disease | Q24646970 | ||
| Widespread microRNA repression by Myc contributes to tumorigenesis | Q24647067 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| Mutations of the BRAF gene in human cancer | Q27860760 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| The let-7 microRNA represses cell proliferation pathways in human cells | Q28240833 | ||
| The miR-34 family in cancer and apoptosis | Q28245865 | ||
| let-7 regulates self renewal and tumorigenicity of breast cancer cells | Q28261263 | ||
| The let-7 family of microRNAs | Q28293181 | ||
| Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia | Q28306681 | ||
| MicroRNAs in cancer | Q30437444 | ||
| microRNAs join the p53 network--another piece in the tumour-suppression puzzle | Q33344707 | ||
| An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. | Q33533878 | ||
| A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer | Q33634277 | ||
| MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma | Q33816470 | ||
| Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase | Q34016286 | ||
| MicroRNA expression profiles associated with mutational status and survival in malignant melanoma | Q34107774 | ||
| OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. | Q34130311 | ||
| MicroRNA signatures differentiate melanoma subtypes | Q34182764 | ||
| Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases | Q34531564 | ||
| MYCN regulates oncogenic MicroRNAs in neuroblastoma | Q34702713 | ||
| The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms | Q34770421 | ||
| Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer | Q34803786 | ||
| Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma | Q34984233 | ||
| Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells | Q35615400 | ||
| The database of experimentally supported targets: a functional update of TarBase | Q37202497 | ||
| Signatures of microRNAs and selected microRNA target genes in human melanoma. | Q39707682 | ||
| Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions | Q39773738 | ||
| miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma | Q39884642 | ||
| MicroRNA-dependent regulation of cKit in cutaneous melanoma | Q39898240 | ||
| Distance constraints between microRNA target sites dictate efficacy and cooperativity | Q40153700 | ||
| NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. | Q54570448 | ||
| Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. | Q54672329 | ||
| Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation | Q73013877 | ||
| Suppression of BRAF(V599E) in human melanoma abrogates transformation | Q79074168 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1959-1970 | |
| P577 | publication date | 2012-07-02 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions | |
| P478 | volume | 32 |
| Q38041704 | Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma |
| Q91736530 | BRAF fusions identified in melanomas have variable treatment responses and phenotypes |
| Q41862341 | Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells |
| Q35148544 | Dosage and temporal thresholds in microRNA proteomics |
| Q34786521 | Down-regulation of miRNA-106b inhibits growth of melanoma cells by promoting G1-phase cell cycle arrest and reactivation of p21/WAF1/Cip1 protein |
| Q86900636 | Essential Role of microRNA in Skin Physiology and Disease |
| Q61417351 | MiRNAs in Malignant Melanoma |
| Q55069393 | MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis. |
| Q38291001 | MicroRNAs in melanocyte and melanoma biology |
| Q39101272 | MicroRNAs in melanoma development and resistance to target therapy |
| Q39069344 | MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. |
| Q26773479 | RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action |
| Q36579789 | Regulation of lipid synthesis by the RNA helicase Mov10 controls Wnt5a production |
| Q39139050 | Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma |
| Q64119763 | Role of miRNAs in Melanoma Metastasis |
| Q38154933 | Skinomics: past, present and future for diagnostic microarray studies in dermatology |
| Q52588029 | Synergistic Action of Dual IGF1/R and MEK Inhibition Sensitizes Childhood Acute Lymphoblastic Leukaemia (ALL) Cells to Cytotoxic Agents and Involves Down-Regulation of STAT6 and PDAP1. |
| Q37419437 | Systems analysis identifies miR-29b regulation of invasiveness in melanoma. |
| Q41255342 | The integrated analysis of RNA-seq and microRNA-seq depicts miRNA-mRNA networks involved in Japanese flounder (Paralichthys olivaceus) albinism |
| Q92887828 | The role of microRNA-30a and downstream snail1 on the growth and metastasis of melanoma tumor |
| Q34965452 | mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation |
| Q38138933 | miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma. |
| Q40720717 | miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma. |
| Q34619395 | miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2. |
| Q37213837 | miR-579-3p controls melanoma progression and resistance to target therapy |
| Q38617229 | miRNAs in melanoma: a defined role in tumor progression and metastasis |
| Q47128749 | microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer |
Search more.